“We encounter approximately two individuals per month showing symptoms of cardiac events on busways, overpasses, and terminals.,” Morales shared. “Our personnel are often the first to reach passengers in distress. We encounter approximately two individuals per month showing symptoms of cardiac events on busways, overpasses, and terminals. Equipping our teams with CPR certification is no longer just an added skill—it is a fundamental enhancement of our duty to protect. This partnership operationalizes the President’s and Secretary Lopez’s mandate: that safety is our paramount deliverable.”
Empowering the 400-Strong Enforcement Team
The first phase of the campaign focuses on training the 400-strong members of the DOTr-SAICT enforcement team. These officers are alternately deployed round the clock to monitor public safety.
Patrick Larraga, Bell-Kenz Pharma’s Corporate Branding and PR Head, emphasized the importance of the DOTr’s reach.
“To build a nation of lifesavers, we must start where the people are,” said Larraga. “The DOTr’s unparalleled network is the ultimate platform for the Sagip CPR mission. By first certifying SAICT and Coast Guard personnel, then extending to major bus consortiums and terminal operators, we are weaving a life-saving safety net directly into the journey of millions of Filipinos.”
A Phased Nationwide Rollout
The program is designed for maximum impact through a strategic, tiered implementation. Starting in Metro Manila, the initiative will focus on high-density areas where commuter volume is highest. After the initial training of SAICT which includes Coast Guard personnel, the program will move to capacitate major bus operators and terminal staff, ensuring a comprehensive safety net for the commuting public.
Following the Metro Manila launch, Bell-Kenz Pharma and the DOTr-SAICT plan to gradually scale the training nationwide, reaching different regional partners and transport hubs across the country to ensure no Filipino commuter is left unprotected.
For more information about Sagip CPR advocacy of Bell-Kenz Pharma, visit www.bell-kenz.net.
